Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy of Tamsulosin and Silodosin on Anatomical Iris Changes in Patients With Benign Prostatic Hyperplasia: A Single-blind Randomized Clinical Trial

NCT07743034 is registered in ClinicalTrials.gov with Mohsen Pourazizi as lead sponsor.

NCT NCT07743034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07743034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy of Tamsulosin and Silodosin on Anatomical Iris Changes in Patients With Benign Prostatic Hyperplasia: A Single-blind Randomized Clinical Trial
Lead sponsor
Mohsen Pourazizi
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
April 30, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, intraoperative floppy iris syndrome, iris diseases, silodosin, tamsulosin, tomography, optical coherence